A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Clinical trial NCT05362773 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05362773
Sponsor: MacroGenics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Acute Myeloid Myelodysplastic Syndromes Classical Hodgkin Lymphoma Leukemia, B-cell Leukemia, Hairy Cell Mastocytosis, Aggressive Systemic Blastic Plasmacytoid Dendritic Cell Neoplasm Chronic Myeloid Leukemia

Start date: 2022-07-13
Primary completion: 2026-11-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.